Abbott Laboratories
ABT· NYSE
ABTAbbott Laboratories
Filed Nov 6, 2009 · 10-Q · 37 days after period end · 0001104659-09-063192
| Metric | Q3 2009 | Q3 2008 |
|---|---|---|
| Revenue | $7.76B | $7.50B |
| Net Income | $1.48B | $1.08B |
| EPS Diluted | $0.95 | $0.69 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
ended Sep 30, 2009 · filed Nov 6, 2009 · 37 d after period end
